view ok quarter progress top-lin
lower tax drove ep beat guidanc leav much
desir concern cl rebas ep
call
ep -msd higher tax
rate/fx/commod weigh ep management also plan
big step ad spend estimate support signific
relaunch core busi innov weak ep
guidanc suggest cl enough flexibl
simultan grow ep time step
invest advertis sharp contrast stapl
compani ko cl long-term ep algorithm question
execut risk elev valuat still high comfort
sidelin maintain market perform rate
growth elev believ stepped-up spend
potenti foreshadow multi-year period increas invest
cl want/ne support innov beyond year
especi competitor sit still believ dynam
pressur margin could reduc cl ep growth potenti
lot ride relaunch ad support cl also call
sharp inflect organ sale growth vs
top-end rang seem like
stretch us highli unlik signific driver
relaunch colgat total hill scienc diet franchis
estim total sale cl also take price
price secur materi step adv/promo support
given recent slow-down organ sale growth think cl
step spend much earlier although management
would argu marri increas spend
signific innov fair point also suggest us
innov pipelin slow estimate organ
sale growth low-end mgmt guidanc
result mix cl report adjust ep
y/i vs our/consensu estim overal ebit
estim tax benefit below-the-
improv behind acceler price vs
emerg market growth turn posit
remain well behind categori growth share
loss continu key countri includ brazil china mexico
 toothpast gross margin remain pressur
y/i driven headwind higher raw materi
net sale flat lsd gross margin ep
-msd lower ep estim
lower price target
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud restructur charg one-tim item
compani data secur llc estim reuter
cl total lot ride upcom total relaunch cl manag left littl doubt
excit ahead global re-launch total unabashedli character
biggest news brand year histori record amount activ plan
manag expect re-launch accomplish host lofti object includ reinvigor
brand drive stepped-up custom engag increas trial/market share almost
goe without say success launch would critic cl hope drive improv
organ sale growth said estim total cl sale re-launch also
bring signific execut risk what note cl track record marqui re-launch
spotti illustr persist share loss recent hand re-launch
cl top line improv ep reflect benefit tax cl report
adjust ep y/i vs our/consensu estim overal ebit
forecast tax benefit below-the-lin item
combin ep beat vs estim organ sale growth ahead
our/consensu estim behind improv price
addit segment-by-seg data detail segment organ sale growth
follow latin america volum vs estimate profit north
america vs estimate europ vs estimate asia pacif vs
estimate africa eurasia vs estimate hill vs estimate
addit detail pleas see individu segment-by-seg bullet
organ sale growth latin america in-lin estim overal
net sale decreas volum decreas price increas fx
headwind manag note volum declin brazil argentina partial
off-set volum gain mexico oper profit decreas declin
reflect lower gross profit partial off-set decreas sg lower gross profit
reflect higher raw packag materi cost incl fx transact cost partial
off-set cost save cl on-going funding-the-growth initi higher price lower
sg expens reflect lower advertis invest term market share cl
maintain toothpast share leadership latin america gain share guatemala
dominican republ panama chile el salvador nicaragua manag call sever
key product contribut growth quarter includ colgat natur extract
colgat total salud visibl colgat tripl action xtra fresh toothpast
north america organ sale growth also in-lin estim
overal net sale volum price increas fx
headwind manag note compani recent profession skin care
acquisit contribut net sale unit volum growth organ unit
volum decreas oper profit decreas basi point
reflect decreas gross profit increas sg expens increas
expens lower gross profit primarili reflect higher raw packag materi cost
partial off-set cost save cl long-stand funding-the-growth initi
higher sg expens reflect higher overhead expens driven increas
logist cost term market share cl maintain leadership posit
toothpast categori quarter ytd market share manag call
sever success product includ colgat optic white stain fighter colgat optic white
stain-less white tom main toothpast
europ organ sale growth well ahead estim net sale
decreas volum price decreas fx
headwind oper profit flat y/i absolut basi y/i
rel basi higher y/i oper profit rel basi reflect increas
gross profit decreas expens partial off-set higher sg expens
higher gross profit reflect cost save cl on-going funding-the-growth initi
partial off-set higher raw packag materi cost higher sg reflect
increas ad spend invest partial off-set lower overhead term
market share cl indic market share expand franc itali greec
netherland denmark belgium product manag highlight oral care
categori includ colgat max white expert complet colgat natur extract charcoal
elmex toothpast colgat advanc whole mouth colgat slim soft advanc
manual toothbrush colgat plax mouthwash
asia pacif organ sale growth in-lin estim
overal net sale decreas volum price decreas
fx headwind manag note volum declin greater
china although partial off-set volum gain india australia oper profit
y/i lower oper profit driven decreas
gross profit increas sg lower gross profit primarili reflect higher raw
packag materi cost partial off-set cost save cl on-going funding-the-
growth initi higher sg expens reflect higher overhead increas ad
invest term market share cl gain share australia philippin
manag call sever key oral care product region includ colgat natur
colgat swarna vedshakti colgat power white colgat sensit pro-relief elmex sensit
africa eurasia organ sale growth vs estim overal net sale
decreas volum price increas fx
headwind oper profit y/i basi point reflect
increas sg partial off-set higher gross profit higher gross profit primarili
reflect cost save cl funding-the-growth initi higher price partial off-set
higher raw packag materi cost higher sg expens reflect higher overhead
increas advertis invest term market share cl gain market share
turkey saudi arabia unit arab emir kenya kazakhstan kuwait product
manag call quarter key contributor sale includ colgat ancient
secret colgat natur extract colgat optic white expert white toothpast colgat
advanc whole mouth clean colgat slim soft advanc manual toothbrush
palmol gourmet palmol lumin oil shower gel
final hill organ sale growth robust vs estim overal net
sale unit volum price fx headwind
oper profit although rel basi oper profit
lower gross profit primarili reflect higher raw packag materi cost
partial off-set cost save cl funding-the-growth initi higher price
lower sg expens reflect lower overhead partial off-set increas ad
china focu manag construct although still dont much get
excit overal cl remain construct trend busi china said
hard find much get excit quarter weak volum growth china continu
weigh perform across broader asia pacif segment cl valu share loss
continu overal manag note consumpt continu look
fine compani price action start work way slowli consum
manag expect see continu sequenti improv growth china
return growth elsewher manag also upbeat compani e-
commerc busi china call launch at-hom whiten kit cl china e-comm
platform note compani plan bring sever new innov
channel acceler growth said see littl truli get excit
maintain cautiou outlook regard cl busi china await evid
sustain turn becom increment construct
brazil lot put take geographi brazil long underpin cl broader
latin america busi balanc slightli encourag modest sequenti
improv cl brazilian busi although share loss continu said
nonetheless concern still mute categori growth coupl heighten promot
activ simpli put fulli convinc competit dynam improv rapidli
need case china await evid sustain turn becom
construct
price manag remain commit broader price strategi manag
reiter stanc price global reflect broader desir premium
compani portfolio off-set underli cost incl transact impact fx
manag indic two-third compani price either rollov price
price accept part compani re-launch total busi
hill scienc diet busi latin america cl manag encourag
competitor follow price lead key geographi mexico although manag
admit nonetheless take time get full sens whether competitor
fulli embrac cl price lead china cl note price work way slowli
consum recal cl took price china bring compani products/brand
mid-tier premium-ti move agre although cogniz could
long-term effect volum
guidanc introduc manag call organ sale growth
in-lin expect head print net sale expect flat lsd
gross margin expect increas howev ep expect declin -msd vs
consensu head print
compani report secur llc
exhibit cl ebit segment
compani report secur llc
market growth soft past sever quarter americaeuropelatin americaasia pacificafrica/eurasiahil sebit margin colgate-palmol compani
exhibit cl organ sale segment
compani report secur llc estim
histor track record stabil clearli entir immun macroeconom
volatil cl one world recogniz consum product compani oral care
person care home care pet nutrit product purchas two-third world
household compani global well ahead ko
believ cl well-posit long-term given unmatch distribut platform across
emerg market net sale per-capita outpac develop market
long-stand track record achiev product save cost effici expect
compani fund growth cost-sav program remain import contributor gross
margin estim individu contribut gross margin basi point bp
annual next sever year reflect increasingli streamlin global manufactur footprint
continu invest rigor analyt capabl said cl top-lin growth slow
materi believ cl face macroeconomic competit pressur across
global oper previous continu view cl track record oper
stabil favor remain concern cl top-lin struggl maintain market perform
forward ev-to-ebitda absolut rel cl current trade ev/ebitda
multipl premium compani histor averag multipl
discount compani histor averag multipl rel peer cl
current trade discount rel hpc peer group discount rel
mega-cap peer forward ev/ebitda multipl basi compar discount
hpc/mega-cap group histor averag forward ev/ebitda basi
discount hpc/mega-cap group histor averag forward ev/ebitda basi price
target impli ev-to-ebitda multipl discount compani current
forward multipl discount one-year discount three-year histor averag
forward ev-to-ebitda multipl believ appropri consid cl recent top-lin
margin challeng elev competit environ key emerg market
colgate-palmol compani cl financi guidanc secur llcbonni herzog except per-shar data sourc tabl compani report secur llc estimatesguid provid januari call fy fy sale salesflat margin bp vs ly bp vs ly bp vs ly bp vs ly growth growth provid januari call april call juli call octob call fy sale growth lsd-msd margin bp vs ly rel absolutelyup rel absolutelyup rel bp vs ly growth dollar basi ldd around around end guidancefi guidanc colgate-palmol compani
forward price-to-earnings absolut rel cl current trade price-to-earnings multipl
premium compani histor averag multipl discount
compani histor averag multipl rel peer cl current trade
premium rel hpc peer group premium rel mega-cap peer
forward price-to-earnings multipl basi compar premium hpc/mega-cap group
year histor averag forward price-to-earnings basi premium hpc/mega-cap group
year histor averag forward price-to-earnings basi price target impli price-to-earnings multipl
discount compani current forward multipl discount one-year
discount three-year histor averag forward price-to-earnings multipl
chart factset secur llc
colgate-palmol compani cl quarterli earn secur llcbonni herzog except per-shar data sourc tabl compani report secur llc profit- inc oper ens relat postretir attribut non-control incom minor share eps- eps- per america ex ex america ex pacif ex ex ex net net sale ex ex percent salescost good revenu build unless sale colgate-palmol compani
compani report secur llc estim
segment data net organ sale unless note north salesnorth sale ex-currencynorth sale growthnorth sale growth ex-currencynorth net salesnorth data incomenorth segment net segment ebitnorth ebit marginnorth cosmet household person
cl volum average price/unit growth y/i
cl dollar share y/i chang
chart nielsen xaoc includ c-store secur llc
compani report nielsen xaoc includ c-store secur llc estim
sale y/yeq sale y/yavg eq price y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end soap-light combin channel data chang bp dollar quarterli north america segment organ sale performanceconsum take-away retail vs manufactur shipment report nielsenreported/estimatedcorrel colgate-palmol compani
exhibit cl european summari data week end
cl european eq volum average price/eq growth y/i
cl european valu share y/i chang
nielsen esp total europ secur llc
nielsen esp total europ secur llc
exhibit cl categori result period end
nielsen scantrack total emerg market secur llc
exhibit cl emerg market valu sale volum average price per growth
nielsen scantrack total emerg market secur llc
note growth rate exclud brazil prior
exhibit cl emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
price target
price target assum price-to-earnings ev-to-ebitda multipl risk price
target includ increment fx headwind local brand competit materi slowdown emerg
cl one attract geograph profil core hpc stapl view said
weak growth stepped-up invest spend give us paus
co base new york new york lead consum product compani
produc market oral care home care person care pet nutrit product compani
signific intern presenc market product countri territori world-wide
brand portfolio includ namesak colgat palmol brand also includ number
global brand includ ajax irish spring hill scienc diet softsoap speed stick suavitel
tom main www colgat com
